GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sangamo Therapeutics Inc (LTS:0R1D) » Definitions » Cyclically Adjusted Book per Share

Sangamo Therapeutics (LTS:0R1D) Cyclically Adjusted Book per Share : $2.96 (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sangamo Therapeutics Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Sangamo Therapeutics's adjusted book value per share for the three months ended in Dec. 2024 was $0.107. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $2.96 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Sangamo Therapeutics's average Cyclically Adjusted Book Growth Rate was -9.60% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -0.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 4.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 7.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Sangamo Therapeutics was 10.60% per year. The lowest was -8.40% per year. And the median was 6.35% per year.

As of today (2025-05-13), Sangamo Therapeutics's current stock price is $0.728. Sangamo Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was $2.96. Sangamo Therapeutics's Cyclically Adjusted PB Ratio of today is 0.25.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sangamo Therapeutics was 13.18. The lowest was 0.09. And the median was 3.33.


Sangamo Therapeutics Cyclically Adjusted Book per Share Historical Data

The historical data trend for Sangamo Therapeutics's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangamo Therapeutics Cyclically Adjusted Book per Share Chart

Sangamo Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.86 3.03 3.07 3.29 2.96

Sangamo Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.29 3.06 3.30 3.06 2.96

Competitive Comparison of Sangamo Therapeutics's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Sangamo Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sangamo Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sangamo Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sangamo Therapeutics's Cyclically Adjusted PB Ratio falls into.


;
;

Sangamo Therapeutics Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sangamo Therapeutics's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.107/133.1571*133.1571
=0.107

Current CPI (Dec. 2024) = 133.1571.

Sangamo Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201503 2.986 99.621 3.991
201506 2.864 100.684 3.788
201509 2.906 100.392 3.854
201512 2.735 99.792 3.649
201603 2.548 100.470 3.377
201606 2.266 101.688 2.967
201609 2.037 101.861 2.663
201612 1.922 101.863 2.512
201703 1.752 102.862 2.268
201706 2.324 103.349 2.994
201709 2.219 104.136 2.837
201712 2.195 104.011 2.810
201803 2.095 105.290 2.649
201806 3.817 106.317 4.781
201809 3.730 106.507 4.663
201812 3.587 105.998 4.506
201903 3.210 107.251 3.985
201906 3.851 108.070 4.745
201909 3.620 108.329 4.450
201912 3.730 108.420 4.581
202003 3.391 108.902 4.146
202006 3.628 108.767 4.442
202009 3.692 109.815 4.477
202012 3.507 109.897 4.249
202103 3.273 111.754 3.900
202106 3.070 114.631 3.566
202109 2.790 115.734 3.210
202112 2.572 117.630 2.912
202203 2.281 121.301 2.504
202206 2.033 125.017 2.165
202209 1.909 125.227 2.030
202212 1.768 125.222 1.880
202303 1.954 127.348 2.043
202306 1.319 128.729 1.364
202309 0.761 129.860 0.780
202312 0.465 129.419 0.478
202403 0.278 131.776 0.281
202406 0.114 132.554 0.115
202409 0.188 133.029 0.188
202412 0.107 133.157 0.107

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Sangamo Therapeutics  (LTS:0R1D) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sangamo Therapeutics's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.728/2.96
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sangamo Therapeutics was 13.18. The lowest was 0.09. And the median was 3.33.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Sangamo Therapeutics Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Sangamo Therapeutics's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sangamo Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
501 Canal Boulevard, Richmond, CA, USA, 94804
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Sangamo Therapeutics Headlines

No Headlines